January 5, 2021
Episode two of the Alderley Park Discovery Podcast covers access to skills in the life sciences sector, with a focus on support for aspiring scientists and UK staffing trends.
In this instalment Dominic Tyer’s guests on the podcast are Sai Life Sciences’ head of global R&D Dean Edney, Joynes & Hunt’s managing director Steve Joynes and Dr Kath Mackay, managing director at Bruntwood SciTech’s Alderley Park.
December 21, 2020
In episode 27 of the pharmaphorum podcast I’m joined by Erin McEachren, who’s EU Regional Vice President at J&J Surgical Vision.
She talks about her priorities at J&J, having joined the company six months ago, the current state of the medical devices sector and some of the trends she’s keeping a close eye on.
November 30, 2020
In episode 26 the pharmaphorum podcast hears from David Solomon, a 30-year life sciences industry veteran who recently took up the position of CEO at the Paris-based biopharmaceutical company Pharnext.
October 30, 2020
GlaxoSmithKline’s Nucala (mepolizumab) last month became the first and only biologic treatment approved in the US for Hypereosinophilic Syndrome (HES).
It’s part of the company’s focus on eosinophil-driven diseases and ahead of that regulatory milestone I spoke with Tiffany Robinson-Smith, who’s global medical affairs lead for biologics at GSK, about eosinophils and why they’re an important element of her company’s research programmes.
September 28, 2020
In this episode of the podcast Gitte discusses telemedicine, GN Hearing’s work in this area – and the impact of COVID-19, plus her time at LEO Pharma.
September 15, 2020
The Alderley Park Discovery Podcast, produced in partnership with pharmaphorum, presents perspectives on UK and global bioscience innovation trends, with input from key experts including managing director and leader of Bruntwood SciTech’s Alderley Park Dr Kath Mackay.
August 27, 2020
Anlnylam’s Brendan Martin joined the pharmaphorum podcast for episode 23 to talk about his company’s work in gene-silencing and how it could offer a route to target the current coronavirus pandemic.
July 30, 2020
Novartis’ Steven Baert joined the pharmaphorum podcast for episode 22 to discuss how COVID-19 will change the face
June 30, 2020
Harvard University launched LabXchange in January and the free science education platform has acquired new resonance during the
May 29, 2020
The COVID-19 pandemic has forced significant changes on the pharmaceutical industry as companies scramble to protect employees, ensure
April 2, 2020
Voice technology like Amazon’s Alexa is taking some big steps forward in healthcare and in the pharmaceutical world
March 9, 2020
One of the biggest barriers to applying precision medicine to clinical trials and patient engagement is getting different
January 8, 2020
In the first pharmaphorum podcast of 2020 Roche’s Conor Megaw talks about his company’s approach to big data
December 11, 2019
Pfizer’s Dr Olivia Ashman joined me for episode 16 of the pharmaphorum podcast, which focuses on the UK
November 14, 2019
Episode 15 of the pharmaphorum podcast marked a return visit for leading life sciences industry authority Professor Brian